Form 4: Oracle Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Oracle Director Naomi O. Seligman sold 2,223 shares of common stock for $196.61 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Naomi O. Seligman, a Director of Oracle Corp (ORCL), reported a sale of common stock.
- The transaction involved the disposition of 2,223 shares of Oracle Common Stock.
- The shares were sold at a price of $196.61 per share.
- This transaction was executed on December 23, 2025.
- The sale was conducted pursuant to a Rule 10b5-1(c) trading plan, indicating it was pre-scheduled.
- Following the transaction, Ms. Seligman directly owns 25,596 shares, and indirectly owns 6,000 shares through her spouse and 14,414 shares through a trust.
Sentiment
Score: 5
Explanation: The sale of shares by a director is generally a neutral event when conducted under a pre-arranged 10b5-1 plan, as it indicates personal financial planning rather than a reaction to new company information. The relatively small number of shares compared to total holdings also contributes to a neutral sentiment.
Positives
- The transaction was executed under a Rule 10b5-1(c) plan, which suggests a pre-scheduled sale for personal financial management rather than a reaction to new, negative company information.
Negatives
- A director's sale of shares, even if pre-planned, reduces their direct equity stake in the company.
Future Outlook
NA
Industry Context
This Form 4 filing details a routine insider transaction by a director of Oracle Corp. Such transactions are common for executives and directors for personal financial planning, often under pre-arranged 10b5-1 plans, and do not inherently reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders may note the director's reduction in direct equity ownership, though the 10b5-1 plan mitigates concerns about adverse signals.
Key Dates
| Date | Description |
|---|---|
| 12/23/2025 | Transaction date for the sale of common stock by Naomi O. Seligman. |
Recommendation
holdThis Form 4 reports a routine, pre-planned sale of a relatively small portion of a director's holdings under a 10b5-1 plan. Such transactions are typically for personal financial management and do not signal a change in the company's fundamental outlook or performance. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Oracle, ORCL, Naomi Seligman, Insider Trading, Form 4, Stock Sale, Director, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.